Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Terminated
The study was halted due to futility concerns based on the unmet benchmarks as specified in the pilot study protocol.
Other terminated trials from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Other Prematurity trials with similar outcome
A PHASE2 clinical study on Prematurity and Pulmonary Hypertension, this trial is terminated or withdrawn. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 12 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
May 2019 — Nov 2020 [monthly]
Terminated PHASE2
-
Apr 2019 — May 2019 [monthly]
Terminated PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .